Press Release | Tuesday, 17 January 2023
Understanding Long Covid: Leopoldina International Virtual Panel discusses the latest research
Most people recover quickly and fully from a SARS-CoV-2 infection. However, some patients continue to experience symptoms weeks or even months after the acute stage of infection. This phenomenon is known as “Long Covid”. In order to better understand the science behind Long Covid, a large number of studies have been initiated at the national and international level. Experts will discuss the latest research at an international virtual podium discussion hosted by the Leopoldina. We cordially invite you to this event and would appreciate an announcement of this date in your medium.
Leopoldina International Virtual Panel
“Understanding Long Covid”
Tuesday, 24th January 2023, 15:00 to 16:00
Online via Zoom
The Leopoldina International Virtual Panel (LIVP) will focus on the latest research regarding the causes and symptoms of Long Covid. It will also discuss evidence-based strategies for preventing long-term consequences of SARS-CoV-2 infection and for treating and supporting patients with Long Covid. The Leopoldina will welcome the following experts to the podium.
- Prof. Michael Edelstein, MD, Associate Professor of Epidemiology and Public Health, Bar-Ilan University, Safed, Israel
- Prof. Akiko Iwasaki, PhD, Sterling Professor of Immunobiology and Molecular, Cellular, and Developmental Biology, Yale University, New Haven, United States
- Prof. Marc Lecuit, MD, PhD, Director of the Biology of Infection Unit, Institut Pasteur, Paris, France
- Prof. Dr. Carmen Scheibenbogen, Acting Director of the Institute of Medical Immunology, Charité Universitätsmedizin Berlin, Germany
This event is part of the Leopoldina’s “International Panel Series”, organised in cooperation with its international partners. The virtual panels provide a space for dialogue between leading scientists and the general public. Previous topics addressed were health behaviour, vaccinations, multimorbidity, mental health, contact tracing, and the role of data collection in the context of the COVID-19 pandemic.
This event is open to all interested parties and will be held in English. Admission is free of charge. Please register before the event. Following registration, you will receive a confirmation email with a link and password for the virtual meeting. When using the Zoom video conference system, the privacy policy of the provider applies.
If you would like to attend as a journalist, please register by email at presse@leopoldina.org.
Follow the Leopoldina on Twitter: www.twitter.com/leopoldina
About the German National Academy of Sciences Leopoldina
As the German National Academy of Sciences, the Leopoldina provides independent science-based policy advice on matters relevant to society. To this end, the Academy develops interdisciplinary statements based on scientific findings. In these publications, options for action are outlined; making decisions, however, is the responsibility of democratically legitimized politicians. The experts who prepare the statements work in a voluntary and unbiased manner. The Leopoldina represents the German scientific community in the international academy dialogue. This includes advising the annual summits of Heads of State and Government of the G7 and G20 countries. With 1,600 members from more than 30 countries, the Leopoldina combines expertise from almost all research areas. Founded in 1652, it was appointed the National Academy of Sciences of Germany in 2008. The Leopoldina is committed to the common good.
Contact:
Dr. Kathrin Kraller and Christian Weidlich
Scientific Officers of the Department of International Relations
E-Mail: international@leopoldina.org
